Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosis01/01/2023 - 12/31/2027 (PI)
NIH/National Heart, Lung, and Blood Institute5K08HL163494-03
Modeling pulmonary fibrosis using patient-specific
iPSCs carrying telomerase mutations10/01/2025 - 09/30/2027 (Key Person / Mentor)
Pulmonary Fibrosis Foundation
Utilizing a pluripotent stem cell model system to unravel the pathogenesis of pulmonary fibrosis07/01/2018 - 06/30/2020 (PI)
Pulmonary Fibrosis Foundation